Exploiting disease genomics to catalyse new medicines
St Catherine’s College, University of Oxford
Manor Road, OX1 3UJ Oxford
london, United Kingdom
Exploiting disease genomics to catalyse new medicines
Structural Genomics Consortium
St Catherine’s College, University of Oxford
Manor Road, OX1 3UJ Oxford
United Kingdom

Schedule of Presentations:

Thursday, June 14, 2018
06:00:00 New Presentation
08:00:00 Registration
08:30:00 Welcome/Opening remarks Gavin Screaton
08:45:00 Introduction to the meeting Opher Gileadi
09:00:00 Learning from Indiana Jones: Choose wisely in selecting targets and chemical probes Paul Workman
09:30:00 Using genomics to inform target selection Jenny Taylor
09:55:00 Selecting targets using Open Targets data
10:20:00 Coffee and posters
11:00:00 Understanding the causes and consequences of obesity Stephen O'Rahilly
11:30:00 New target discovery and qualification using genome-scale data David J. Collier
11:55:00 Targeting aminoadipate-semialdehyde synthase (AASS) for pyridoxine-dependent epilepsy (PDE)
12:20:00 A TEP for DPAGT1: from protein glycosylation diseases to antibiotic design Liz Carpenter
12:45:00 Lunch and posters
13:40:00 Lunchtime workshop
14:00:00 Targeting DNA repair pathways for cancer therapeutics : From structures to TEPs and beyond Joseph Newman
14:25:00 Chemoproteomics as a tool in drug discovery Jennifer Ward
14:50:00 Proteogenomic characterization of CDK12 functions using a novel inhibitor Gregg Morin
15:15:00 Neuropsychiatry - can we do better Simon Ward
15:40:00 Coffee and posters
16:20:00 How can the biomedical community in the UK exploit TEPs?
16:45:00 We should all be I'MPATIENT - Open Science to accelerate discoveries with patient and disease foundations Wen Hwa Lee
17:00:00 Building partnerships to target a rare paediatric glioma
17:15:00 No substitute for activity
17:40:00 Closing remarks
3D Tissue Models
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.